Cheshire, CT, United States of America

Daniel Kita

This inventor holds 2 USPTO granted patents. Top assignee: University of Connecticut. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Kita. Retrieved from https://idiyas.com/inventor/daniel-kita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Daniel Kita: Inventor in Biotechnology

Introduction

Daniel Kita is an inventor based in Cheshire, Connecticut, whose patent work focuses on antibody compositions and their potential applications in cancer detection and treatment. He is associated with the University of Connecticut and is credited with 2 patents.

Latest Patents

Kita’s listed patents share the title “Antibody and antigen-binding fragment compositions targeting cell surface antigens in tumors and methods of use thereof.” The described invention includes an isolated antibody or antigen-binding fragment with a heavy-chain variable region containing three complementary determining regions: HCDR1, GYRLSELS; HCDR2, ISGWDGNT; and HCDR3, ARASGYNY. The antibody or fragment specifically binds human HSP90, particularly HSP90 beta. The patent description also covers detection and therapeutic methods using these antibodies or fragments.

Career Highlights

Kita’s patent portfolio reflects research into antibody-based approaches targeting HSP90 beta. The described compositions and methods connect molecular recognition with potential diagnostic and therapeutic uses in tumors.

Collaborations

Kita’s listed coworkers include Kevin Patrick Claffey and Charan Devarakonda. His work is associated with the University of Connecticut.

Conclusion

Daniel Kita’s two patents highlight antibody-based research aimed at tumor detection and therapy, with a focus on binding human HSP90 beta.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…